{"id":1369,"createDateTime":"2026-08-12T04:15:21.214Z","archiveDateTime":"2027-12-31T00:00:00.000Z","name":"Medication-Related Osteonecrosis of the Jaw (MRONJ) and Osteoporosis","image":"8c4c071a6aaf8b1a9bcb1fd512eb112139c29ab8a970878215410ac9","imageThumbnail":"c5c976a9d9686a6b4364971a7987bb1e88ebae607f5ffcfb4dc3ea69","about":"Healthy Bones Australia has released its first Consensus Statement on MRONJ and osteoporosis. This activity provides a quick guide to this new guideline.  \n\nThis activity comprises a short educational video, followed by a reflective activity. Participants must complete both components to qualify for 30 minutes of Reviewing Performance (RP) Hours. \n\n# Learning Outcomes\n1. Outline the best practice approach to assessing and managing MRONJ risk in osteoporosis care.   \n2. Critically reflect on recent interactions with patients requiring dental procedures while receiving ARD therapy. \n3. Apply guideline-aligned strategies to minimise MRONJ risk in patients with osteoporosis. \n\n# Provider\nThe Provider of this activity is [Praxhub](https://app.praxhub.com/orgs/1). Praxhub is an accredited Major Provider under the RACGP CPD Program. For any questions regarding this activity please contact support@praxhub.com. ","type":"video","summaryViewCount":100,"startDateTime":null,"durationSecs":475,"organisation":{"id":101,"name":"Arrotex","logoImage":"343d2282723763f021df947917df828894bcf90cd0942a7b794bdcd8","logoImageThumbnail":"4cb9c205c6d9ce99135b8445d977a6b5da5a4f07cbd1b9811fbd93f2","industry":"Pharmaceutical"},"provider":{"id":1,"name":"Praxhub","logoImage":"7d8c82e84cfeb7556fa842c1980c93b8144ab0959b0630c17e557baf","logoImageThumbnail":"78ba1e568155afb45aa67fc6f7337c076b0a1aa9182ceb80ac9b1095","industry":"Health Technology"},"commentCount":0,"likeCount":1,"presenters":[{"id":59011,"specialty":{"id":55,"name":"Endocrinology"},"name":"Prof Peter Ebeling","title":null,"profileImage":"130014b42b62e293b3198b082e23b913e49ce03d6287f0d721a2b15a","profileImageThumbnail":"ea7f67280acb2346d48aac22862cc31b66f5b5d598580ee4b15ae9c8"}],"relatedEducation":[{"id":1363,"name":"Oral Contraception: From Evidence to Practice ","image":"42d0a4f8a46f82c540c4c00afded1b3fc29d0ff0c0c808504d3cc458","imageThumbnail":"4b3f571a5a638bcdc9c3d417204de62c4244bd5b7e63d21fe20d6a61","type":"zoom-webinar","startDateTime":"2026-09-09T09:30:00.000Z","durationSecs":5400,"associationEducationTypes":["EA","MO","RP"],"organisation":{"id":101,"name":"Arrotex"}},{"id":1373,"name":"Hormonal Acne Management for General Practice","image":"8980d52fa2537eff660b08b44f79752a006b26b23d223206ddf22a8a","imageThumbnail":"bb0b3a191abc66b9631de005b87931e2765d514fc7d71ae5d2fd8f57","type":"zoom-webinar","startDateTime":"2026-10-08T08:30:00.000Z","durationSecs":5400,"associationEducationTypes":["EA","MO","RP"],"organisation":{"id":101,"name":"Arrotex"}},{"id":1371,"name":"Fracture risk perception and medication adherence","image":"8a32746a58f9ae41f671a7e9c947bb28f50471654044468665d3c5e7","imageThumbnail":"0563278e7f8893527677202c291cc4fc492c520ca53ccc1b743c91e6","type":"video","startDateTime":null,"durationSecs":454,"associationEducationTypes":["RP"],"organisation":{"id":101,"name":"Arrotex"}},{"id":1370,"name":"Pharmacological considerations for long-term antiresorptive drug (ARD) therapy ","image":"486aaf82a6cd773abd54f88e7e0df641b671075061b3281e755c87af","imageThumbnail":"bf7fe9ca785b08607ae90187607860a533437433ba322ada091c4858","type":"video","startDateTime":null,"durationSecs":677,"associationEducationTypes":["RP"],"organisation":{"id":101,"name":"Arrotex"}},{"id":1368,"name":"Osteoporotic Fracture vs Atypical Femoral Fracture (AFF)","image":"e47038a006cf6a26f6fcc26839a6a41a501306708d30a1df05682b1b","imageThumbnail":"365e97ca3567b7d1accf0e2f7a837e17c9f3e7b999384095779d33c8","type":"video","startDateTime":null,"durationSecs":370,"associationEducationTypes":["RP"],"organisation":{"id":101,"name":"Arrotex"}},{"id":1367,"name":"Diagnosing osteoporosis and the latest treatment pathways","image":"4086d7dafc37fcd4356cd14c54e79767426d7f838825d6adc9e4684a","imageThumbnail":"e92410f1c9fa8ea1dd05b02c7b9594a42922d0be0c0ec815fee88113","type":"video","startDateTime":null,"durationSecs":855,"associationEducationTypes":["RP"],"organisation":{"id":101,"name":"Arrotex"}}]}